These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 27527815

  • 1. Early impact of Ontario's human papillomavirus (HPV) vaccination program on anogenital warts (AGWs): A population-based assessment.
    Guerra FM, Rosella LC, Dunn S, Wilson SE, Chen C, Deeks SL.
    Vaccine; 2016 Sep 07; 34(39):4678-4683. PubMed ID: 27527815
    [Abstract] [Full Text] [Related]

  • 2. Health service utilisation for anogenital warts in Ontario, Canada prior to the human papillomavirus (HPV) vaccine programme introduction: a retrospective longitudinal population-based study.
    Guerra FM, Rosella LC, Dunn S, Wilson SE, Chen C, Deeks SL.
    BMJ Open; 2016 Mar 10; 6(3):e009914. PubMed ID: 26966057
    [Abstract] [Full Text] [Related]

  • 3. The early impact of human papillomavirus vaccination on anogenital warts in Québec, Canada.
    Steben M, Ouhoummane N, Rodier C, Sinyavskaya L, Brassard P.
    J Med Virol; 2018 Mar 10; 90(3):592-598. PubMed ID: 28980715
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts.
    Smith LM, Strumpf EC, Kaufman JS, Lofters A, Schwandt M, Lévesque LE.
    Pediatrics; 2015 May 10; 135(5):e1131-40. PubMed ID: 25917991
    [Abstract] [Full Text] [Related]

  • 6. Incidence of anogenital warts after the introduction of the quadrivalent HPV vaccine program in Manitoba, Canada.
    Righolt CH, Willows K, Kliewer EV, Mahmud SM.
    PLoS One; 2022 May 10; 17(4):e0267646. PubMed ID: 35472093
    [Abstract] [Full Text] [Related]

  • 7. Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination.
    Shing JZ, Hull PC, Zhu Y, Gargano JW, Markowitz LE, Cleveland AA, Pemmaraju M, Park IU, Whitney E, Mitchel EF, Griffin MR.
    Papillomavirus Res; 2019 Jun 10; 7():141-149. PubMed ID: 30980966
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Quadrivalent HPV vaccine effectiveness against anogenital warts: A registry-based study of 2,2 million individuals.
    Nygård S, Nygård M, Orumaa M, Hansen BT.
    Vaccine; 2023 Aug 23; 41(37):5469-5476. PubMed ID: 37516572
    [Abstract] [Full Text] [Related]

  • 12. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
    Woestenberg PJ, King AJ, van der Sande MA, Donken R, Leussink S, van der Klis FR, Hoebe CJ, Bogaards JA, van Benthem BH, Medical Microbiological Laboratories, Public Health Services.
    J Infect; 2017 Apr 23; 74(4):393-400. PubMed ID: 28126492
    [Abstract] [Full Text] [Related]

  • 13. Incidence of anogenital warts: epidemiological risk factors and real-life impact of human papillomavirus vaccination.
    Tyros G, Mastraftsi S, Gregoriou S, Nicolaidou E.
    Int J STD AIDS; 2021 Jan 23; 32(1):4-13. PubMed ID: 33167803
    [Abstract] [Full Text] [Related]

  • 14. Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients.
    Woestenberg PJ, Guevara Morel AE, Bogaards JA, Hooiveld M, Schurink-van 't Klooster TM, Hoebe CJPA, van der Sande MAB, van Benthem BHB.
    Clin Infect Dis; 2021 Jul 15; 73(2):291-297. PubMed ID: 32421775
    [Abstract] [Full Text] [Related]

  • 15. Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women.
    Brotons M, Monfil L, Roura E, Duarte-Salles T, Casabona J, Urbiztondo L, Cabezas C, Bosch FX, de Sanjosé S, Bruni L.
    Prev Med; 2020 Sep 15; 138():106166. PubMed ID: 32565118
    [Abstract] [Full Text] [Related]

  • 16. A reduced national incidence of anogenital warts in young Danish men and women after introduction of a national quadrivalent human papillomavirus vaccination programme for young women--an ecological study.
    Sandø N, Kofoed K, Zachariae C, Fouchard J.
    Acta Derm Venereol; 2014 May 15; 94(3):288-92. PubMed ID: 24150529
    [Abstract] [Full Text] [Related]

  • 17. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
    Lurie S, Mizrachi Y, Chodick G, Katz R, Schejter E.
    Gynecol Oncol; 2017 Aug 15; 146(2):299-304. PubMed ID: 28602548
    [Abstract] [Full Text] [Related]

  • 18. Impact of the human papillomavirus (HPV) vaccine on genital wart diagnoses at Auckland Sexual Health Services.
    Oliphant J, Perkins N.
    N Z Med J; 2011 Jul 29; 124(1339):51-8. PubMed ID: 21952330
    [Abstract] [Full Text] [Related]

  • 19. Increasing incidence of anogenital warts with an urban-rural divide among males in Manitoba, Canada, 1990-2011.
    Thompson LH, Nugent Z, Blanchard JF, Ens C, Yu BN.
    BMC Public Health; 2016 Mar 03; 16():219. PubMed ID: 26939696
    [Abstract] [Full Text] [Related]

  • 20. Declines in Anogenital Warts Among Age Groups Most Likely to Be Impacted by Human Papillomavirus Vaccination, United States, 2006-2014.
    Flagg EW, Torrone EA.
    Am J Public Health; 2018 Jan 03; 108(1):112-119. PubMed ID: 29161070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.